NANOBIOTIX (NANO.PA)
FR0011341205 - Common Stock
| 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 38.58M | 83.92M | 119.15M | 25.09M | 24.70M | |||
| Cash Equivalents | -1.00K | 83.92M | 119.15M | 35.09M | 36.20M | |||
| Marketable Securities | 2.81M | N/A | 0.00 | 10.00M | 11.50M | |||
| Receivables | 7.99M | 6.93M | 3.88M | 8.36M | 5.35M | |||
| Other Current Assets | 2.98M | 2.21M | 2.22M | 2.67M | 1.10M | |||
| Total Current Assets | 52.36M | 93.06M | 125.25M | 46.13M | 42.65M | |||
| Non-Current Assets | ||||||||
| PPE Net | 7.12M | 8.19M | 8.26M | 9.39M | 2.88M | |||
| Investments And Advances | 291.00K | 519.00K | 505.00K | 529.00K | 558.00K | |||
| Intangibles | 1.00K | 4.00K | 21.00K | 163.00K | 102.00K | |||
| Other Non-Current Assets | -1.00K | 8.71M | N/A | N/A | 0.00 | |||
| Total Non-Current Assets | 7.41M | 8.71M | 8.78M | 10.08M | 3.54M | |||
| TOTAL ASSETS | 59.77M | 101.77M | 134.03M | 56.20M | 46.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 4.06M | 7.40M | 4.37M | 591.00K | 0.00 | |||
| Accrued Expenses | 6.59M | 5.08M | 6.53M | 5.13M | 4.11M | |||
| Accounts Payable | N/A | N/A | 7.11M | 7.77M | 2.58M | |||
| Other Current Liabilities | 27.28M | 24.36M | 8.14M | 8.63M | 7.49M | |||
| Total Current Liabilities | 37.94M | 36.84M | 19.04M | 14.35M | 11.59M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 46.35M | 35.56M | 41.13M | 40.56M | 16.73M | |||
| Other Non-Current Liabilities | 2.53M | 2.58M | 3.39M | 3.21M | 3.63M | |||
| Total Non-Current Liabilities | 48.88M | 38.13M | 44.52M | 43.77M | 20.36M | |||
| TOTAL LIABILITIES | 86.81M | 74.98M | 63.56M | 58.11M | 31.95M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -284.32M | -230.46M | -186.66M | -155.98M | -109.40M | |||
| Additional Paid In Capital | 255.76M | 255.77M | 255.74M | 153.14M | 122.80M | |||
| Common Shares | 1.05M | 1.04M | 1.03M | 672.00K | 589.00K | |||
| Treasury Stock | -228.00K | -202.00K | -196.00K | -169.00K | -124.00K | |||
| Other Shareholders' Equity | 700.00K | 642.00K | 555.00K | 434.00K | 381.00K | |||
| Shares Outstanding | 34.85M | 34.81M | 34.42M | 22.40M | 19.62M | |||
| Tangible Book Value per Share | -0.78 | 0.77 | 2.05 | -0.09 | 0.72 | |||
| Total Shareholders' Equity | -27.05M | 26.79M | 70.47M | -1.91M | 14.24M | |||
| TOTAL LIABILITIES AND EQUITY | 59.77M | 101.77M | 134.03M | 56.20M | 46.20M | |||
| Statistics | ||||||||
| Debt/Equity | -1.71 | 1.33 | 0.58 | -21.26 | 1.17 | |||
| Current Ratio | 1.38 | 2.53 | 6.58 | 3.22 | 3.68 | |||
| Return On Assets (ROA) | -95.44% | -46.19% | -25.06% | -90.59% | -65.69% | |||
| Return On Equity (ROE) | N/A | -175.45% | -47.67% | N/A | -213.05% | |||
All data in EUR